Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIB, Randomized, Double-blind, Two-arm, Multi-center, Placebo-controlled, Study to Assess the Efficacy and Safety of EN3324 (Axomadol) in Subjects With Moderate to Severe Chronic Low Back Pain

NCT01043263 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT01043263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01043263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIB, Randomized, Double-blind, Two-arm, Multi-center, Placebo-controlled, Study to Assess the Efficacy and Safety of EN3324 (Axomadol) in Subjects With Moderate to Severe Chronic Low Back Pain
Lead sponsor
Grünenthal GmbH
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2011
Enrollment
236 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low back pain